Since the onset of the coronavirus disease 2019 (COVID-19), numerous neutralizing
antibodies (NAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the devastating global COVID-19 pandemic announced by WHO in March 2020. Through …

Molnupiravir, an oral prodrug of N-hydroxycytidine (NHC), previously demonstrated broad in
vitro antiviral activity against multiple RNA viruses and has shown a high barrier to the …

The formation of the fibrillar structure of amyloid proteins/peptides is believed to be
associated with neurodegenerative diseases, such as Alzheimer's disease, Parkinson's …

Since the introduction of the novel SARS-CoV-2 virus (COVID-19) in late 2019, various new
variants have appeared with mutations that confer resistance to the vaccines and …

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has devastated public health and the …

Severe acute respiratory coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus
disease 2019 (COVID-19), has led to a pandemic with severe economic losses. The viral …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) heavily burdens human health. Multiple …

Since its emergence, the COVID-19 threat has been sustained by a series of transmission
waves initiated by new variants of the SARS-CoV-2 virus. Some of these arise with higher …

The binding of the receptor binding domain (RBD) of the SARS-CoV-2 spike protein to the
host cell receptor angiotensin-converting enzyme 2 (ACE2) is the first step in human viral …